Literature DB >> 22184065

Myc regulates the transcription of the PRC2 gene to control the expression of developmental genes in embryonic stem cells.

Francesco Neri1, Alessio Zippo, Anna Krepelova, Alessandro Cherubini, Marina Rocchigiani, Salvatore Oliviero.   

Abstract

Myc family members are critical to maintain embryonic stem cells (ESC) in the undifferentiated state. However, the mechanism by which they perform this task has not yet been elucidated. Here we show that Myc directly upregulates the transcription of all core components of the Polycomb repressive complex 2 (PRC2) as well as the ESC-specific PRC2-associated factors. By expressing Myc protein fused with the estrogen receptor (Myc-ER) in fibroblasts, we observed that Myc, binding to the regulatory elements of Suz12, Ezh2, and Eed, induces the acetylation of histones H3 and H4 and the recruitment of elongating RNA polymerase II at their promoters. The silencing of both c-Myc and N-Myc in ESC results in reduced expression of PRC2 and H3K27me3 at Polycomb target developmental regulators and upregulation of genes involved in primitive endoderm differentiation. The ectopic expression of PRC2 in ESC, either silenced for c-Myc and N-Myc or induced to differentiate by leukemia inhibitory factor (LIF) withdrawal, is sufficient to maintain the H3K27me3 mark at genes with bivalent histone modifications and keep repressed the genes involved in ESC differentiation. Thus, Myc proteins control the expression of developmental regulators via the upregulation of the Polycomb PRC2 complex.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22184065      PMCID: PMC3272981          DOI: 10.1128/MCB.06148-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

1.  Core transcriptional regulatory circuitry in human embryonic stem cells.

Authors:  Laurie A Boyer; Tong Ihn Lee; Megan F Cole; Sarah E Johnstone; Stuart S Levine; Jacob P Zucker; Matthew G Guenther; Roshan M Kumar; Heather L Murray; Richard G Jenner; David K Gifford; Douglas A Melton; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

2.  PRC2 complexes with JARID2, MTF2, and esPRC2p48 in ES cells to modulate ES cell pluripotency and somatic cell reprogramming.

Authors:  Zhuo Zhang; Amanda Jones; Chiao-Wang Sun; Chao Li; Chia-Wei Chang; Heui-Yun Joo; Qian Dai; Matthew R Mysliwiec; Li-Chen Wu; Yahong Guo; Wei Yang; Kaimao Liu; Kevin M Pawlik; Hediye Erdjument-Bromage; Paul Tempst; Youngsook Lee; Jinrong Min; Tim M Townes; Hengbin Wang
Journal:  Stem Cells       Date:  2011-02       Impact factor: 6.277

3.  Eed/Sox2 regulatory loop controls ES cell self-renewal through histone methylation and acetylation.

Authors:  Hiroki Ura; Kazuhiro Murakami; Tadayuki Akagi; Keita Kinoshita; Shukuro Yamaguchi; Shinji Masui; Hitoshi Niwa; Hiroshi Koide; Takashi Yokota
Journal:  EMBO J       Date:  2011-05-03       Impact factor: 11.598

4.  c-Myc-regulated microRNAs modulate E2F1 expression.

Authors:  Kathryn A O'Donnell; Erik A Wentzel; Karen I Zeller; Chi V Dang; Joshua T Mendell
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

5.  Transcriptional repression: the dark side of myc.

Authors:  Barbara Herkert; Martin Eilers
Journal:  Genes Cancer       Date:  2010-06

6.  Analysis of Myc bound loci identified by CpG island arrays shows that Max is essential for Myc-dependent repression.

Authors:  Daniel Y L Mao; John D Watson; Pearlly S Yan; Dalia Barsyte-Lovejoy; Fereshteh Khosravi; W Wei-Lynn Wong; Peggy J Farnham; Tim H-M Huang; Linda Z Penn
Journal:  Curr Biol       Date:  2003-05-13       Impact factor: 10.834

7.  Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells.

Authors:  Jamy C Peng; Anton Valouev; Tomek Swigut; Junmei Zhang; Yingming Zhao; Arend Sidow; Joanna Wysocka
Journal:  Cell       Date:  2009-12-24       Impact factor: 41.582

8.  A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells.

Authors:  Zirong Li; Sara Van Calcar; Chunxu Qu; Webster K Cavenee; Michael Q Zhang; Bing Ren
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-13       Impact factor: 11.205

Review 9.  The Polycomb complex PRC2 and its mark in life.

Authors:  Raphaël Margueron; Danny Reinberg
Journal:  Nature       Date:  2011-01-20       Impact factor: 49.962

10.  The Myc transactivation domain promotes global phosphorylation of the RNA polymerase II carboxy-terminal domain independently of direct DNA binding.

Authors:  Victoria H Cowling; Michael D Cole
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

View more
  54 in total

1.  TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway.

Authors:  F Neri; D Dettori; D Incarnato; A Krepelova; S Rapelli; M Maldotti; C Parlato; P Paliogiannis; S Oliviero
Journal:  Oncogene       Date:  2014-11-03       Impact factor: 9.867

Review 2.  MYC: connecting selective transcriptional control to global RNA production.

Authors:  Theresia R Kress; Arianna Sabò; Bruno Amati
Journal:  Nat Rev Cancer       Date:  2015-09-18       Impact factor: 60.716

Review 3.  MYC and transcription elongation.

Authors:  Peter B Rahl; Richard A Young
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

4.  The polycomb protein Ezh2 impacts on induced pluripotent stem cell generation.

Authors:  Xiaolei Ding; Xiaoying Wang; Stephanie Sontag; Jie Qin; Paul Wanek; Qiong Lin; Martin Zenke
Journal:  Stem Cells Dev       Date:  2014-01-21       Impact factor: 3.272

Review 5.  Chromatin accessibility dynamics during cell fate reprogramming.

Authors:  Dongwei Li; Xiaodong Shu; Ping Zhu; Duanqing Pei
Journal:  EMBO Rep       Date:  2021-01-22       Impact factor: 8.807

6.  Direct reprogramming by oncogenic Ras and Myc.

Authors:  Irene Ischenko; Jizu Zhi; Ute M Moll; Alice Nemajerova; Oleksi Petrenko
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

7.  c-Rel regulates Ezh2 expression in activated lymphocytes and malignant lymphoid cells.

Authors:  Wen Hao Neo; Jun Feng Lim; Raelene Grumont; Steve Gerondakis; I-Hsin Su
Journal:  J Biol Chem       Date:  2014-09-29       Impact factor: 5.157

Review 8.  Role of EZH2 histone methyltrasferase in melanoma progression and metastasis.

Authors:  Fade Mahmoud; Bradley Shields; Issam Makhoul; Laura F Hutchins; Sara C Shalin; Alan J Tackett
Journal:  Cancer Biol Ther       Date:  2016-04-22       Impact factor: 4.742

9.  ALK and MYCN: when two oncogenes are better than one.

Authors:  Zhihui Liu; Carol J Thiele
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

10.  Polycomb repressive complex 2 is required for MLL-AF9 leukemia.

Authors:  Tobias Neff; Amit U Sinha; Michael J Kluk; Nan Zhu; Mohamed H Khattab; Lauren Stein; Huafeng Xie; Stuart H Orkin; Scott A Armstrong
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.